Xiangui He
Shanghai, Shanghai Municipality, 201103, China
NCT Number: NCT05894382
This study uses 1.585 double helix defocus lens PC lenses with a unique optical design that includes a globally coherent visible area and complementary left and right helices that can form clear images. In addition, the helical arrangement and reduced slit area can generate defocusing signals, inhibiting the development of myopia. Therefore, based on previous research, this study plans to evaluate the safety and effectiveness of 1.585 double helix defocus lens PC frame eyeglasses in controlling the progression of myopia in children and adolescents through a randomized controlled clinical trial.
This study is active but is not currently recruiting participants.
Notify Me6 year–13 year
All sexes
Interventional
Not applicable
Shanghai, Shanghai Municipality, 201103, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Double Helix Design Defocus Lens Spectacle wearing more than 10h/day.
single-vision spetacle lens wearing more than 10h/day.
Time frame: 1 year
cycloplegic SE change
Time frame: 1 year
Time frame: 1 year
Shanghai Eye Disease Prevention and Treatment Center
Other
A Randomized Controlled Study on the Effectiveness, Safety and Adaptability of Double Helix Design Defocus Lens Spectacle Frames for Correction of Visual Acuity in Children and Adolescents, and Control of Myopia.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07264361
Eye Diseases, Myopia
Guangzhou, Guangdong, China
View Trial DetailsNCT03818880
Eye Diseases, Myopia
Waterloo, Ontario, Canada
View Trial DetailsNCT06563700
Eye Diseases, Myopia
Shanghai, China
View Trial DetailsNCT06647160
Eye Diseases, Myopia
Guangzhou, Guangdong, China
View Trial Details